Minerva Neurosciences, Inc Common Stock (NASDAQ: NERV) last traded at $3.03, down 4.72% on the session. The quote above updates while this page is open; the figures below are drawn from Minerva Neurosciences, Inc Common Stock’s own filings and are restated only when a new one is published.
Minerva Neurosciences, Inc Common Stock trades on NASDAQ under the ticker NERV. Its market capitalisation is $144.68 million.
Valuation measures for Minerva Neurosciences, Inc Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $144.68M |
|---|---|
| Enterprise value | $416.67M |
| Beta | 1.48 |
Trailing-twelve-month figures tagged in Minerva Neurosciences, Inc Common Stock's XBRL filings with the SEC.
| Net income (TTM) | -$394.35M |
|---|---|
| Cash |
|---|
| $24.65M |
Range and volume for NERV over the past 52 weeks.
| 52-week high | $12.46 |
|---|---|
| 52-week low | $2.24 |
| Volume | 13.8K |
| Average volume | 180.4K |
| Previous close | $3.18 |
Invest a chosen dollar amount in Minerva Neurosciences, Inc Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell NERV.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.